These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2900947)

  • 21. Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease.
    Kulkarni S; Powles R; Sirohi B; Treleaven J; Saso R; Horton C; Atra A; Ortin M; Rudin C; Goyal S; Sankpal S; Meller S; Pinkerton CR; Mehta J; Singhal S
    Bone Marrow Transplant; 2003 Jul; 32(2):165-70. PubMed ID: 12838281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential use of thalidomide in the therapy of graft-versus-host disease--a review of clinical and laboratory information.
    Wood PM; Proctor SJ
    Leuk Res; 1990; 14(5):395-9. PubMed ID: 2189044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalidomide treatment for chronic graft-versus-host disease.
    Heney D; Norfolk DR; Wheeldon J; Bailey CC; Lewis IJ; Barnard DL
    Br J Haematol; 1991 May; 78(1):23-7. PubMed ID: 2043478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quest to improve marrow transplant success yields new approaches to graft-vs-host disease.
    Kirn TF
    JAMA; 1987 Sep; 258(11):1438-9. PubMed ID: 3306001
    [No Abstract]   [Full Text] [Related]  

  • 25. Thalidomide induction of bone marrow transplantation tolerance.
    Vogelsang GB; Hess AD; Gordon G; Brundrette R; Santos GW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2658-61. PubMed ID: 3547944
    [No Abstract]   [Full Text] [Related]  

  • 26. Thalidomide--the need for a new clinical evaluation of an old drug.
    Ehninger G; Eger K; Stuhler A; Schuler U
    Bone Marrow Transplant; 1993; 12 Suppl 3():S26-8. PubMed ID: 8124253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thalidomide responsive chronic pulmonary GVHD.
    Forsyth CJ; Cremer PD; Torzillo P; Iland HJ; Young GA
    Bone Marrow Transplant; 1996 Feb; 17(2):291-3. PubMed ID: 8640183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sclerodermatous chronic graft-versus-host disease--a report of four pediatric cases.
    Tolland JP; Devereux C; Jones FC; Bingham EA
    Pediatr Dermatol; 2008; 25(2):240-4. PubMed ID: 18429789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of thalidomide for treatment or prevention of chronic graft-versus-host disease.
    Flowers ME; Martin PJ
    Leuk Lymphoma; 2003 Jul; 44(7):1141-6. PubMed ID: 12916865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graft-versus-host disease.
    Kaitin KI
    N Engl J Med; 1991 Aug; 325(5):357-8. PubMed ID: 2057040
    [No Abstract]   [Full Text] [Related]  

  • 31. Response to thalidomide therapy in refractory chronic graft-versus-host disease.
    Browne PV; Weisdorf DJ; DeFor T; Miller WJ; Davies SM; Filipovich A; McGlave PB; Ramsay NK; Wagner J; Enright H
    Bone Marrow Transplant; 2000 Oct; 26(8):865-9. PubMed ID: 11081386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extensive chronic graft-versus-host disease of skin successfully treated with thalidomide.
    Nair V; Sharma A; Ghosh I; Arora S; Sahai K; Dutta V
    J Assoc Physicians India; 2005 Nov; 53():988-90. PubMed ID: 16515241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thalidomide once more in the spotlight].
    de Jong-van den Berg LT; Rutgers J; Cornel MC
    Ned Tijdschr Geneeskd; 1998 Nov; 142(46):2509-12. PubMed ID: 10028338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thalidomide use in pediatric patients.
    Bessmertny O; Pham T
    Ann Pharmacother; 2002 Mar; 36(3):521-5. PubMed ID: 11895068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thalidomide and graft verses host disease: basis for a new indication and side effects].
    López Gil JA
    Med Clin (Barc); 1992 Oct; 99(14):545-8. PubMed ID: 1434991
    [No Abstract]   [Full Text] [Related]  

  • 36. Life-threatening acute pancreatitis due to thalidomide therapy for chronic graft-versus-host disease.
    Chung LW; Yeh SP; Hsieh CY; Liao YM; Huang HH; Lin CY; Chiu CF
    Ann Hematol; 2008 May; 87(5):421-3. PubMed ID: 18040684
    [No Abstract]   [Full Text] [Related]  

  • 37. Thalidomide for chronic GVHD.
    Sastry PS; Powles RL
    Bone Marrow Transplant; 1998 Nov; 22(9):933-4. PubMed ID: 9827827
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation.
    Biagi JJ; Mileshkin L; Grigg AP; Westerman DW; Prince HM
    Bone Marrow Transplant; 2001 Dec; 28(12):1145-50. PubMed ID: 11803357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of severe erythrodermic acute graft-versus-host disease with photochemotherapy.
    Kunz M; Wilhelm S; Freund M; Zimmermann R; Gross G
    Br J Dermatol; 2001 Apr; 144(4):901-2. PubMed ID: 11298559
    [No Abstract]   [Full Text] [Related]  

  • 40. Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease.
    Chao NJ; Parker PM; Niland JC; Wong RM; Dagis A; Long GD; Nademanee AP; Negrin RS; Snyder DS; Hu WW; Gould KA; Tierney DK; Zwingenberger K; Forman SJ; Blume KG
    Biol Blood Marrow Transplant; 1996 May; 2(2):86-92. PubMed ID: 9118303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.